Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000060 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 23, 2026 |
| Document Date | Jan 22, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
2,064
Total Value
$44,923.79
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VP/Chief Accounting Officer | Common Stock | โ | Jan 22, 2026 | Sale | 2,064 | $21.77 | $44,923.79 | 49,805 | Direct | โ | View Details |